Please login to the form below

Not currently logged in
Email:
Password:

Takeda appoints Rob Gallo as head of corporate communications, Europe and Canada

Will lead efforts to combine communications efforts in two regions

Rob Gallo - TakedaJapan-based Takeda Pharmaceuticals has promoted its interim head of corporate communications for Europe Rob Gallo to a permanent role that also covers Canada.

Gallo had been in his interim position since 2010, overseeing Europe-wide media campaigns, and will now be based at Takeda's regional headquarters in Zurich, Switzerland.

His new responsibilities will include unifying local communication teams as Takeda prepares to combine its Canadian and European businesses into a single Takeda subsidiary, ensuring communication aligns to the company's new strategic model as well as preparing teams for the launch of several products.

Gallo said: “I am delighted to be joining Takeda permanently to help deliver corporate objectives in what is a very exciting stage of the company's development.”

Before joining Takeda, Gallo was a director of Operandi Partners, a corporate communications and issues management consultancy based in London. 

In addition to his pharmaceutical experience, he has also held senior communications posts across a range of FMCG companies in the UK, Italy and Australia.

13th July 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GEM Marketing Ltd

GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....

Latest intelligence

A new reality for healthcare
When mobile phones came onto the mass market it would have been difficult to see how they were to develop into the ubiquitous multimedia devices they are now. Their power,...
Digital-green-grey.jpg
Are you getting these benefits from your digital technology?
Your organisation switched from ‘paper to glass’, buying the latest mobile devices and hiring digital agencies to fill them with eye-catching content. But what happened?...
Alzheimer's: the numbers we cannot forget
In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as looking at the some of the...

Infographics